Screening of subclinical hepatic encephalopathy

Journal of Hepatology

Volumn 32, Issue 5, 2000, Pages 748-753

  Groeneweg, Michael ^a   Moerland, Wendy ^a   Quero, Juan C ^a   Hop, Wim C J ^b   Krabbe, Paul F ^b   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Liver cirrhosis; Quality of life; Sickness Impact Profile; Subclinical hepatic encephalopathy

Indexed keywords

ADULT; AGED; ALERTNESS; ARTICLE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REST; SLEEP;

EID: 0034020717     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80243-3     Document Type: Article

References (22)

1. Conn HO. The hepatic encephalopathies. Conn HO, Bircher J. Hepatic Encephalopathy: Syndromes and Therapies. 1994;1-12 Medi-Ed Press, Bloomington.
2. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant, non-shunted patients with cirrhosis. J Hepatol. 3:1986;75-82.
3. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroenceph Clin Neurophysiol. 75:1990;289-295.
4. Quero JC, Hartmann IJC, Meulstee J, Hop WCJ, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology. 24:1996;556-560.
5. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis. 16:1996;321-328.
6. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, DÖlle W. Latent portosystemic encephalopathy. Nature of cerebral function defects and their effect on fitness to drive. Dig Dis Sc. 26:1981;622-630.
7. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJC, Essink-Bot ML, Hop WCJ, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 28:1998;45-49.
8. Bergner M, Bobbitt RA, Cartner WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 19:1981;787-805.
9. Van der Rijt CCD. Hepatic encephalopathy: clinical and experimental studies. dissertation The Netherlands: Erasmus University Rotterdam. 1991.
10. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
11. Reitan RM. Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills. 8:1958;271-276.
12. SchÖnleber R. Standardisierung eines psychometrischen Tests zur Erfassung der hepatischen Encephalopathie [Thesis]. Tübingen (FRG). 1989.
13. Lezak MD. Neuropsychological Assessment. 3rd ed. 1995;Oxford University Press, New York.
14. Stinissen J, Willems PJ, Coetsier P, Hulsman WLL. Handleiding bij de Nederlandstalige bewerking van de Wechsler Adult Intelligence Scale. 1970;Swets & Zeitlinger B.V. Lisse, The Netherlands.
15. Van der Rijt CCD, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroenceph Clin Neurophysiol. 57:1984;423-426.
16. De Melker RA, Touw-Otten F, Jacobs HM, Luttik A. De waarde van de 'Sickness Impact Profile' als uitkomstmeting. Ned Tijdschr Geneeskd. 134:1990;946-948.
17. Jacobs HM, Luttik A, Touw-Otten FWMM, De Melker RA. De 'Sickness Impact Profile': resultaten van een valideringsonderzoek van de Nederlandse versie. Ned Tijdschr Geneeskd. 134:1990;1950-1952.
18. Sackett DL. The selection of diagnostic data. Sackett DL, Haynes RB, Guyatt GH, Tugwell R. Clinical Epidemiology. A Basic Science for Clinical Medicine, 2nd ed. 1991;69-152 Little, Brown & Comp. Boston.
19. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology. 29:1999;264-270.
20. Tarter RE, Sandford SL, Hays AL, Carra JP. Hepatic injury correlates with neuropsychologic impairment. Intern J Neurosc. 44:1989;75-82.
21. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med. 140:1980;519-521.
22. Sarin SK, Nundy S. Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver. 5:1985;142-146.